We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

This advertisement has not loaded yet, but your article continues below. The Prince Edward Island Regulatory and Appeals Commission (IRAC) announced a one-cent change to regular gas prices overnight, ...